Cargando…

(18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging

This study assessed the role of (18)F-FDG PET-CT (PET/CT) to detect the cartilage and paraglottic infiltration in advanced glottic cancer comparing the results with those of conventional imaging (CI) (contrast-enhanced computed tomography and/or magnetic resonance). In addition, we assessed the prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Paone, G., Martucci, F., Espeli, V., Ceriani, L., Treglia, G., Ruberto, T., Richetti, A., Piantanida, R., Giovanella, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755300/
https://www.ncbi.nlm.nih.gov/pubmed/31558887
http://dx.doi.org/10.1155/2019/4051206
_version_ 1783453204433862656
author Paone, G.
Martucci, F.
Espeli, V.
Ceriani, L.
Treglia, G.
Ruberto, T.
Richetti, A.
Piantanida, R.
Giovanella, L.
author_facet Paone, G.
Martucci, F.
Espeli, V.
Ceriani, L.
Treglia, G.
Ruberto, T.
Richetti, A.
Piantanida, R.
Giovanella, L.
author_sort Paone, G.
collection PubMed
description This study assessed the role of (18)F-FDG PET-CT (PET/CT) to detect the cartilage and paraglottic infiltration in advanced glottic cancer comparing the results with those of conventional imaging (CI) (contrast-enhanced computed tomography and/or magnetic resonance). In addition, we assessed the prognostic value of quantitative parameters, measured on baseline PET/CT, in terms of event-free survival (EFS) and overall survival (OS). We retrospectively analyzed 27 patients with glottic squamous cell carcinoma stage III and IVA, treated in our institute between 2010 and 2016, comparing PET/CT, performed for staging and radiotherapy planning, and CI findings. Cohen's K was used to compare concordance between PET/CT and CI. Imaging findings were correlated with endoscopic evaluation and histological reports (gold standard (GS)). All lesions shown by CI were also detected by PET/CT imaging, and in 5 cases, a better definition of local infiltration was achieved with PET/CT than CI (5 CT). Sensitivity, specificity, and accuracy of PET/CT and CT were 95%, 86%, and 93% and 70%, 86%, and 74% for, respectively. MRI showed sensitivity and specificity of 100%. One false-negative (FN) cases and 1 false-positive (FP) case were observed with PET/CT with no difference compared to MRI (10 cases). Six FN cases and 1 FP case were observed with CT. Cohen's K was 0.60 (PET vs. CI) and 0.80 (PET vs. GS). Patients were followed-up for at least 24 months to calculate EFS and OS. 13 local recurrence and 7 deaths were recorded. Among quantitative PET parameters, baseline MTV was the most powerful predictor of outcome. Our data suggest a reliable sensitivity and accuracy of PET/CT in the evaluation of local extension, proving a useful method for initial local staging in addition to the well-established role in lymph-node and distant sites assessment. Furthermore, pretreatment MTV provides better prognostic information than other PET/CT parameters.
format Online
Article
Text
id pubmed-6755300
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67553002019-09-26 (18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging Paone, G. Martucci, F. Espeli, V. Ceriani, L. Treglia, G. Ruberto, T. Richetti, A. Piantanida, R. Giovanella, L. Contrast Media Mol Imaging Research Article This study assessed the role of (18)F-FDG PET-CT (PET/CT) to detect the cartilage and paraglottic infiltration in advanced glottic cancer comparing the results with those of conventional imaging (CI) (contrast-enhanced computed tomography and/or magnetic resonance). In addition, we assessed the prognostic value of quantitative parameters, measured on baseline PET/CT, in terms of event-free survival (EFS) and overall survival (OS). We retrospectively analyzed 27 patients with glottic squamous cell carcinoma stage III and IVA, treated in our institute between 2010 and 2016, comparing PET/CT, performed for staging and radiotherapy planning, and CI findings. Cohen's K was used to compare concordance between PET/CT and CI. Imaging findings were correlated with endoscopic evaluation and histological reports (gold standard (GS)). All lesions shown by CI were also detected by PET/CT imaging, and in 5 cases, a better definition of local infiltration was achieved with PET/CT than CI (5 CT). Sensitivity, specificity, and accuracy of PET/CT and CT were 95%, 86%, and 93% and 70%, 86%, and 74% for, respectively. MRI showed sensitivity and specificity of 100%. One false-negative (FN) cases and 1 false-positive (FP) case were observed with PET/CT with no difference compared to MRI (10 cases). Six FN cases and 1 FP case were observed with CT. Cohen's K was 0.60 (PET vs. CI) and 0.80 (PET vs. GS). Patients were followed-up for at least 24 months to calculate EFS and OS. 13 local recurrence and 7 deaths were recorded. Among quantitative PET parameters, baseline MTV was the most powerful predictor of outcome. Our data suggest a reliable sensitivity and accuracy of PET/CT in the evaluation of local extension, proving a useful method for initial local staging in addition to the well-established role in lymph-node and distant sites assessment. Furthermore, pretreatment MTV provides better prognostic information than other PET/CT parameters. Hindawi 2019-09-11 /pmc/articles/PMC6755300/ /pubmed/31558887 http://dx.doi.org/10.1155/2019/4051206 Text en Copyright © 2019 G. Paone et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Paone, G.
Martucci, F.
Espeli, V.
Ceriani, L.
Treglia, G.
Ruberto, T.
Richetti, A.
Piantanida, R.
Giovanella, L.
(18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
title (18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
title_full (18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
title_fullStr (18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
title_full_unstemmed (18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
title_short (18)F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
title_sort (18)f-fdg-pet/ct imaging in advanced glottic cancer: a tool for clinical decision in comparison with conventional imaging
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755300/
https://www.ncbi.nlm.nih.gov/pubmed/31558887
http://dx.doi.org/10.1155/2019/4051206
work_keys_str_mv AT paoneg 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT martuccif 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT espeliv 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT cerianil 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT tregliag 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT rubertot 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT richettia 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT piantanidar 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging
AT giovanellal 18ffdgpetctimaginginadvancedglotticcanceratoolforclinicaldecisionincomparisonwithconventionalimaging